Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHA:688393)

China flag China · Delayed Price · Currency is CNY
27.67
-0.09 (-0.32%)
At close: Feb 13, 2026
Market Cap2.59B +57.9%
Revenue (ttm)371.03M -25.1%
Net Income-19.11M
EPS-0.21
Shares Out93.57M
PE Ration/a
Forward PEn/a
Dividend0.10 (0.36%)
Ex-Dividend DateMay 29, 2025
Volume1,631,535
Average Volume3,164,346
Open27.84
Previous Close27.76
Day's Range27.36 - 28.24
52-Week Range20.75 - 46.59
Beta0.60
RSI47.90
Earnings DateApr 29, 2026

About SHA:688393

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China and internationally. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridizatio... [Read more]

Sector Healthcare
Founded 2005
Employees 779
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688393
Full Company Profile

Financial Performance

In 2024, SHA:688393's revenue was 470.79 million, a decrease of -5.33% compared to the previous year's 497.29 million. Earnings were 21.29 million, a decrease of -46.85%.

Financial Statements